Howard Kaufman

Howard Kaufman

Chief Executive Officer at
Ankyra Therapeutics, Inc.
65 year
Health Services
Consumer Services
Commercial Services

Profile

Howard L.
Kaufman
currently works at Ankyra Therapeutics, Inc., as President, Chief Executive Officer & Director from 2022.
Dr. Kaufman also formerly worked at Rush University Medical Center, as Director-Cancer Center from 2009 to 2013, Rutgers Cancer Institute of New Jersey, as Chief Surgical Officer from 2014 to 2017, International Society for Biological Therapy of Cancer, as President from 2014 to 2016, and Replimune Group, Inc., as Chief Medical Officer from 2017 to 2019.
Dr. Kaufman received his doctorate degree in 1986 from Loyola University of Chicago.

Howard Kaufman active positions

CompaniesPositionStart
Chief Executive Officer 22/03/2022

Former positions of Howard Kaufman

CompaniesPositionEnd
REPLIMUNE GROUP, INC. Chief Tech/Sci/R&D Officer 31/12/2019
Corporate Officer/Principal 01/01/2017
President 01/01/2016
Corporate Officer/Principal 01/01/2013
See the detail of Howard Kaufman's experience

Training of Howard Kaufman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

49

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Consumer Services

Health Services

Health Services

Commercial Services

Health Technology

Health Services

  1. Stock Market
  2. Insiders
  3. Howard Kaufman